BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10149546)

  • 1. The preparation of platelet concentrates by the light-spin/hard-spin technique.
    Dzik WH
    Transfus Sci; 1991; 12(3):171-81. PubMed ID: 10149546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of random donor leukocyte-poor platelets by cytapheresis.
    Olthuis HP; Stienstra S; Puylaert CE; Verhagen CM; Bär BM
    Transfus Sci; 1993 Apr; 14(2):195-7. PubMed ID: 10148612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet-leukocyte aggregates as a marker for platelet activation in platelet concentrates].
    Chakroun T; Abdelkefi S; Bouslama M; Houissa B; Zaier M; Miled A; Kortas M; Yacoub S
    Transfus Clin Biol; 2008 Sep; 15(4):148-53. PubMed ID: 18760949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation of leukocyte-reduced platelet concentrates from buffy coats using a novel separation apparatus].
    Müller N; Krüssel H
    Beitr Infusionsther Transfusionsmed; 1994; 32():52-4. PubMed ID: 9480156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
    Pietersz RN
    Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of leukocyte contamination on storage of platelet concentrates from buffy coats].
    Klüter H; Klinger M; Bauhaus M; Kirchner H
    Beitr Infusionsther Transfusionsmed; 1994; 32():61-5. PubMed ID: 9480159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of cytokine accumulation in platelets obtained with the COBE spectra apheresis system.
    Palmer DS; Aye MT; Dumont L; Dumont D; McCombie N; Giulivi A; Rutherford B; Trudel E; Hashemi-Tavoularis S
    Vox Sang; 1998; 75(2):115-23. PubMed ID: 9784664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of platelet concentrate during preparation and storage.
    Rinder HM; Snyder EL
    Blood Cells; 1992; 18(3):445-56; discussion 457-60. PubMed ID: 1283703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?
    Schrezenmeier H; Seifried E
    Vox Sang; 2010 Jul; 99(1):1-15. PubMed ID: 20059760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system.
    Riggert J; Humpe A; Simson G; Köhler M
    Vox Sang; 1998; 74(3):182-8. PubMed ID: 9595646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
    Seghatchian J
    Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of random versus apheresis platelet concentrates.
    Andreu G; Vasse J; Sandid I; Tardivel R; Semana G
    Transfus Clin Biol; 2007 Dec; 14(6):514-21. PubMed ID: 18417401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphocyte interactions in platelet concentrates from buffy coats. Determination of proliferating cells using Ki-67 antibodies].
    Müller-Steinhardt M; Klüter H; Kirchner H
    Beitr Infusionsther Transfusionsmed; 1994; 32():66-8. PubMed ID: 9480160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis.
    Zimmermann R; Reske S; Metzler P; Schlegel A; Ringwald J; Eckstein R
    Vox Sang; 2008 Jul; 95(1):20-5. PubMed ID: 18444946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
    Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
    Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a platelet apheresis technique for the preparation of leukocyte-reduced platelet concentrates.
    Zingsem J; Glaser A; Weisbach V; Zimmermann R; Neidhardt B; van Waeg G; Eckstein R
    Vox Sang; 1998; 74(3):189-92. PubMed ID: 9595647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differentiation of leukocytes in thrombocyte concentrates by APAAP staining].
    Müller-Steinhardt M; Klüter H; Kirchner H
    Beitr Infusionsther; 1992; 30():127-30. PubMed ID: 1284687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of platelet concentrates (PC) from buffy coat (BC) using the bottom and top drainage (BAT) system.
    Kretschmer V; Biermann E; Loh H
    Beitr Infusionsther; 1990; 26():65-70. PubMed ID: 1703903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological changes associated with pH changes during storage of platelet concentrates.
    Solberg C; Holme S; Little C
    Beitr Infusionther Klin Ernahr; 1986; 15():107-17. PubMed ID: 3753404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.